Association of Periodontitis and Non-Alcoholic Fatty Liver Disease

Not Applicable

Recruiting

• Conditions: on-alcoholic Fatty Liver Disease; C07.465.714.533

• Registration Number: RBR-3n32q2k
• Lead Sponsor: niversidade Federal do Rio de Janeiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-11
• Last Update Posted: 25 June 2024
• Study Completion: 2025-06-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients from the Hepatology Service of the Clementino Fraga Filho University Hospital diagnosed with non-alcoholic fatty liver disease; both gender

Exclusion Criteria

Totally edentulous patients; patients with less than 10 teeth present; smoking patients; patients who have used antibiotic medication in the last six months at baseline, anti-inflammatories or medications potentially inducing gingival hyperplasia (phenytoin, nifedipine and cyclosporine) in the last three months; patients with indication of antibiotic prophylaxis for periodontal clinical approaches; patients undergoing periodontal treatment in the last six months; patients undergoing orthodontic treatment; and patients with any syndrome, except metabolic syndrome; patients who have already used medication that induces hepatic steatosis (e.g. amiodarone, tamoxifen and methotrexate); third molars, residual roots, teeth with non-carious cervical lesion, caries lesion or subgingival restoration, teeth with altered development associated with protective and/or supporting periodontal tissues, teeth involved in local pathological processes, teeth with suspected fracture, teeth with previous or current history of endodontic accident/complication, or even endoperiodontal injury, will not be considered in the periodontal evaluation

Study & Design

• Study Type: Intervention
• Study Design: Not specified